Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 4.09
- Piotroski Score 3.00
- Grade Buy
- Symbol (STOK)
- Company Stoke Therapeutics, Inc.
- Price $12.99
- Changes Percentage (-0.88%)
- Change -$0.12
- Day Low $12.99
- Day High $13.09
- Year High $17.58
Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. Its lead clinical candidate is STK-001, which is in phase I/IIa clinical trial to treat Dravet syndrome, a severe and progressive genetic epilepsy; and STK-002, which is in preclinical stage for the treatment of autosomal dominant optic atrophy. It had entered into a license and collaboration agreement with Acadia Pharmaceuticals Inc. for the discovery, development, and commercialization of novel RNA-based medicines for the treatment of severe and rare genetic neurodevelopmental diseases of the central nervous system. The company was formerly known as ASOthera Pharmaceuticals, Inc. and changed its name to Stoke Therapeutics, Inc. in May 2016. Stoke Therapeutics, Inc. was incorporated in 2014 and is headquartered in Bedford, Massachusetts.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 11/04/2024
- Fiscal Year End N/A
- Average Stock Price Target $22.00
- High Stock Price Target $58.00
- Low Stock Price Target $18.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$2.42
- Trailing P/E Ratio -6.14
- Forward P/E Ratio -6.14
- P/E Growth -6.14
- Net Income $-104,699,000
Income Statement
Quarterly
Annual
Latest News of STOK
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Ballot box fires stoke fears of election violence
Recent ballot drop box fires in the Pacific Northwest have raised concerns about election security and violence. Experts worry about voter distrust and potential threats in the 2024 election. Official...
By The Hill | 2 days ago -
North Yorkshire man arrested over burglary of Ben Stokes's home
Durham police arrested a 32-year-old man in connection with a burglary at Ben Stokes' home, where his OBE medal and valuables were stolen. Stokes expressed concern for his family's well-being and emph...
By The Guardian | 3 days ago -
Kelsea Ballerini and Chase Stokes Rock 'Grease' Couples Costume at Heidi Klum's Halloween Party
Country singer Kelsea Ballerini and actor Chase Stokes rocked coordinated looks at various events, including Halloween party, awards shows, and premieres. Their supportive relationship shines both on ...
By PEOPLE.com | 4 days ago
